RESULTS OF CHEMOTHERAPY IN PATIENTS WITH MULTIDRUG-RESISTANT TUBERCULOSIS IN THE REGIONS OF THE RUSSIAN FEDERATION

RESULTS OF CHEMOTHERAPY IN PATIENTS WITH MULTIDRUG-RESISTANT TUBERCULOSIS IN THE REGIONS OF THE RUSSIAN FEDERATION

The paper analyzes the results of treatment in 5,396 patients with multidrug-resistant tuberculosis who were treated in the regions of the Russian Federation under the Global Fund Round 4 project based on the recommended World Health Organization principles in the software management of drug-resista...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. V. Testov, S. A. Sterlikov, I. A. Vasilyeva, V. V. Erokhin, T. Ch. Kesaeva
Format:	Article
Language:	Russian
Published:	New Terra Publishing House 2014-04-01
Series:	Туберкулез и болезни лёгких
Subjects:	chemotherapy multidrug resistant tuberculosis
Online Access:	https://www.tibl-journal.com/jour/article/view/56
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

THE EFFICIENCY OF TREATMENT IN MULTIDRUG-RESISTANT TUBERCULOSIS PATIENTS REGISTERED IN 2010
by: S. A. Sterlikov, et al.
Published: (2014-03-01)

Long-term results of treatment in multidrug-resistant mycobacterium tuberculosis patients interrupting a chemotherapy cycle
by: A. I. Gaida, et al.
Published: (2014-12-01)

Assessment of effectiveness of the empiric treatment regimen in tuberculosis patients suspected with multiple drug resistance in the Russian Federation
by: Sergey A. Sterlikov, et al.
Published: (2018-11-01)

Simulation of Conditions and Results of Implementation of Short-Course Treatment Regimes in Tuberculosis Patients
by: V. S. Burykhin, et al.
Published: (2023-12-01)

THE CHARACTERISTICS AND RESULTS OF A BASIC TREATMENT CYCLE IN NEW-ONSET PULMONARY TUBERCULOSIS PATIENTS REGISTERED IN 2011
by: S. A. Sterlikov
Published: (2014-07-01)

Defects in the statistical accounting of patients with tuberculosis with its multidrug-resistant pathogen
by: V. B. Galkin
Published: (2015-02-01)

Risk Factors for Multidrug-resistant Tuberculosis
by: Cleopas Martin Rumende
Published: (2018-04-01)

Risk Factors for Multidrug-resistant Tuberculosis
by: Cleopas Martin Rumende
Published: (2018-04-01)

CLINICAL CASES OF FOCAL PULMONARY TUBERCULOSIS IN CHILDREN WITH MINIMUM INVOLVEMENT IN MULTIDRUG RESISTANCE IN MYCOBACTERIUM TUBERCULOSIS
by: M. F. Gubkina, et al.
Published: (2015-03-01)

Amplification of drug resistance against the background of inadequate chemotherapy for pulmonary tuberculosis
by: I. A. Burmistrova, et al.
Published: (2019-09-01)

Efficiency of surgical treatment of multidrug-resistant Pulmonary Tuberculosis within the DOTS-PLUS program
by: A. K. Strelis, et al.
Published: (2009-02-01)

Economic aspects of using new chemotherapy regimens for multidrug and extensively drugresistant tuberculosis
by: А. V. Kukurika
Published: (2022-10-01)

Immediate Outcomes of Surgical Treatment for Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis
by: D. B. Giller, et al.
Published: (2024-08-01)

Comorbidity in phthisiatric practice: multidrug-resistant tuberculosis and laryngeal cancer (2 case reports)
by: O. M. Raznatovska, et al.
Published: (2020-02-01)

Tuberculosis preventive chemotherapy in the HIV infected in the regions of the Russian Federation with high prevalence of HIV infection
by: E. B. Tsybikova, et al.
Published: (2016-02-01)

Differentiating between Intestinal Tuberculosis and Crohn’s Disease May Be Complicated by Multidrug-resistant Mycobacterium tuberculosis
by: Seung Wook Hong, et al.
Published: (2021-07-01)

RISK FACTORS FOR INEFFECTIVE CHEMOTHERAPY IN PATIENTS WITH MULTIDRUG-RESISTANT TUBERCULOSIS
by: O. V. Filinyuk, et al.
Published: (2014-01-01)

Justification of Chemotherapy Duration in Patients with Multiple and Pre-Extensive Drug Resistant Tuberculosis in the Russian Federation
by: A. I. Gayda, et al.
Published: (2023-01-01)

Effectiveness of using Glutamyl-cysteinyl-glycine disodium immunomodulator in patients with destructive multidrug-resistant tuberculosis of lungs
by: A. S. Shalmin, et al.
Published: (2015-08-01)

TUBERCULOSIS IN THE CORRECTIONAL FACILITIES OF RUSSIA IN 2012
by: I. M. Son, et al.
Published: (2014-07-01)

Lethal Risk Factors in Patients with Rifampicin Resistant Tuberculosis according to Federal Register of Tuberculosis Cases
by: I. A. Vasilyeva, et al.
Published: (2024-12-01)

A Rare Presentation of Acute Multifocal Skeletal Multidrug-resistant Tuberculosis
by: Rahul Puli, et al.
Published: (2023-04-01)

Update on multidrug-resistant tuberculosis preventive therapy toward the global tuberculosis elimination
by: Alberto Matteelli, et al.
Published: (2025-06-01)

Prediction of risk factors associated with the development of multidrug-resistant tuberculosis in patients with tuberculosis
by: Haiyan Chen, et al.
Published: (2025-07-01)

Resurgence of multidrug-resistant tuberculosis during the COVID-19 pandemic in Korea
by: Tae Hoon Kim, et al.
Published: (2025-06-01)

TUBERCULOSIS IN THE PENITENTIARY SYSTEM IN THE COUNTRIES OF EUROPE AND THE RUSSIAN FEDERATION
by: I. A. Vasilyeva, et al.
Published: (2018-06-01)

Efficacy and safety of treatment of HIV-associated multidrug-resistant tuberculosis. Systematic review and meta-analysis
by: A. V. Kukurika
Published: (2025-03-01)

Challenges of Multidrug-Resistant Tuberculosis Meningitis: Current Treatments and the Role of Glutathione as an Adjunct Therapy
by: Mohammad J. Nasiri, et al.
Published: (2024-12-01)

The Epidemiological Tuberculosis Situation in the Russian Penitentiary System: Main Trends and Challenges
by: V. V. Testov, et al.
Published: (2022-08-01)

Specific features of the clinical course and chemotherapy of tuberculosis in children exposed to tuberculosis with different drug resistance patterns
by: M. E. Lozovskaya, et al.
Published: (2019-10-01)

Tuberculosis Situation in the Years of the COVID-19 Pandemic – 2020-2021
by: I. A. Vasilyeva, et al.
Published: (2022-04-01)

Treatment results of patients with multiple and extensive drug resistance registered in 2012 in the Russian Federation and in the world
by: S. A. Sterlikov, et al.
Published: (2016-01-01)

Epidemiological characteristics and risk factors analysis of multidrug-resistant tuberculosis among tuberculosis population in Huzhou City, Eastern China
by: Chen Haiyan, et al.
Published: (2025-03-01)

Risk factors for multidrug resistance in pulmonary tuberculosis patients with diabetes mellitus
by: Lianpeng Wu, et al.
Published: (2025-01-01)

Determination of Duration of the Intensive Phase of Chemotherapy for Respiratory Tuberculosis in Children without Bacterial Excretion and at No Risk of Multiple and Extensive Drug Resistance
by: M. F. Gubkinа, et al.
Published: (2021-07-01)

Multidrug-resistant tuberculosis in Rawalpindi, Pakistan
by: Muhammad Khurram, et al.
Published: (2011-09-01)

Predictors of failure in treatment according program DOTS-PLUS in patients suffering from multidrug-resistant tuberculosis
by: I. G. Felker, et al.
Published: (2012-08-01)

Bedaquiline and linezolid regimens for multidrug-resistant tuberculosis: a systematic review and meta-analysis
by: Mahdis Cheraghi, et al.
Published: (2025-03-01)

Clinical features of pregnancy in multidrug-resistant tuberculosis and type I diabetes mellitus comorbidities (a case report).
by: O. M. Raznatovska, et al.
Published: (2019-11-01)

Factors associated with tuberculosis drug resistance among presumptive multidrug resistance tuberculosis patients identified in a DRTB surveillance study in western Kenya
by: Albert Okumu, et al.
Published: (2024-12-01)